Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11697633 Polymorphic compounds and uses thereof

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Navitor Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

July 11, 2023

0

Patent Application Number

177374780

Date Filed

May 5, 2022

0

Patent Citations

US Patent 10414782 Modulators of sestrin-GATOR2 interaction and uses thereof

0

US Patent 10912750 Modulators of Sestrin-GATOR2 interaction and uses thereof

0

US Patent 10752644 Modulators of Sestrin-GATOR2 interaction and uses thereof

0

US Patent 7087648 Methods for modulating macrophage proliferation using polyamine analogs

0

US Patent 7390799 Apoptosis promoters

0

US Patent 8138347 Quinoline derivatives as PI3 kinase inhibitors

0

US Patent 10100066 Modulators of sestrin-GATOR2 interaction and uses thereof

0

Patent Primary Examiner

0

CPC Code

0

0

0

The present invention relates to compounds and methods useful for selectively modulating mTORC1 activity.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11697633 Polymorphic compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool